Similar articles

• Characterization of the cellular immune response in Chagas' disease patients.

  Castes M, Araujo Z, Mosca W. Castes M, et al. Acta Cient Venez. 1986;37(5):547-53. Acta Cient Venez. 1986. PMID: 3129894 No abstract available.
• A comparison of the molecular biology of trypanosomes and leishmaniae, and its impact on the development of methods for the diagnosis and vaccination of leishmaniasis and Chagas disease.

  O'Daly JA. O'Daly JA. Biol Res. 1993;26(1-2):219-24. Biol Res. 1993. PMID: 7670534
• [Immunodiagnostic findings in sera of patients with leishmaniasis, Chagas' disease, malaria and amebiasis in endemic regions of Venezuela (author's transl)].

  Salfelder A, Mannweiler E. Salfelder A, et al. Tropenmed Parasitol. 1981 Sep;32(3):194-6. Tropenmed Parasitol. 1981. PMID: 6285563 German.
• Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.

  Ouaissi A, Ouaissi M. Ouaissi A, et al. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):102-14. Arch Immunol Ther Exp (Warsz). 2005. PMID: 15928579 Review.
• The importance of aberrant T-cell responses in Chagas disease.

  DosReis GA, Freire-de-Lima CG, Nunes MP, Lopes MF. DosReis GA, et al. Trends Parasitol. 2005 May;21(5):237-43. doi: 10.1016/j.pt.2005.03.008. Trends Parasitol. 2005. PMID: 15837613 Review.